Brief: Plx Pharma Q3 Loss Per Share $0.39
09/11/2018 11:53
Nov 9 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA INC REPORTS THIRD QUARTER 2018 RESULTS
* Q3 LOSS PER SHARE $0.39
* Q3 REVENUE $200,000
* REMAIN ON TARGET FOR MID-2020 LAUNCH OF VAZALORE
* AS OF SEPTEMBER 30, 2018, COMPANY HAD $16.5 MILLION IN
CASH AND
CASH EQUIVALENTS
* REMAIN ON TARGET FOR MID-2020 LAUNCH OF VAZALORE.
Source text for Eikon: ID:nGNX7VMnT2
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice